Neogenomics (NEO) Net Cash Flow: 2009-2025
Historic Net Cash Flow for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to $9.4 million.
- Neogenomics' Net Cash Flow rose 35.69% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$197.8 million, marking a year-over-year decrease of 454.86%. This contributed to the annual value of $24.5 million for FY2024, which is 69.08% down from last year.
- Latest data reveals that Neogenomics reported Net Cash Flow of $9.4 million as of Q3 2025, which was up 104.90% from -$191.4 million recorded in Q2 2025.
- Over the past 5 years, Neogenomics' Net Cash Flow peaked at $372.5 million during Q1 2021, and registered a low of -$250.2 million during Q2 2021.
- Its 3-year average for Net Cash Flow is -$9.0 million, with a median of $9.4 million in 2025.
- Per our database at Business Quant, Neogenomics' Net Cash Flow soared by 1,330.45% in 2023 and then crashed by 926.11% in 2025.
- Neogenomics' Net Cash Flow (Quarterly) stood at -$26.9 million in 2021, then soared by 89.05% to -$2.9 million in 2022, then soared by 1,330.45% to $36.2 million in 2023, then plummeted by 86.15% to $5.0 million in 2024, then skyrocketed by 35.69% to $9.4 million in 2025.
- Its Net Cash Flow stands at $9.4 million for Q3 2025, versus -$191.4 million for Q2 2025 and -$20.8 million for Q1 2025.